Literature DB >> 22064264

HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice.

Gerasimos J Zaharatos1, Jian Yu, Craig Pace, Yang Song, Sandhya Vasan, David D Ho, Yaoxing Huang.   

Abstract

Using murine IgG subclass molecules (IgG1 or IgG2a) synthetically fused to HIV-1 or influenza test antigens, we explored the potential for IgG Fc scaffolds to augment immunogenicity. Each antigen (Ag) was grafted onto a hinge-Fc scaffold containing all critical residues necessary for interaction with effector cells, thus retaining effector functions of the native IgG subclass. We hypothesized that the differential affinity of FcγRs for specific IgG subclasses would influence the magnitude of immune responses elicited by immunization with an Ag-IgG Fc fusion vaccine. We demonstrate here that the antigen-specific humoral response elicited by Ag-IgG2a fusion vaccines is at least tenfold greater than that elicited by native antigen, that this response is superior to that elicited by Ag-IgG1, and that the augmented antigen-specific humoral response elicited is Fcγ receptor-dependent.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22064264     DOI: 10.1016/j.vaccine.2011.10.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques.

Authors:  Zhanna Shubin; Weizhong Li; Bhawna Poonia; Guido Ferrari; Celia LaBranche; David Montefiori; Xiaoping Zhu; C David Pauza
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

2.  Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses.

Authors:  Ann J Hessell; Rebecca Powell; Xunqing Jiang; Christina Luo; Svenja Weiss; Vincent Dussupt; Vincenza Itri; Alisa Fox; Mariya B Shapiro; Shilpi Pandey; Tracy Cheever; Deborah H Fuller; Byung Park; Shelly J Krebs; Maxim Totrov; Nancy L Haigwood; Xiang-Peng Kong; Susan Zolla-Pazner
Journal:  Cell Rep       Date:  2019-07-23       Impact factor: 9.423

3.  A novel synthetic bipartite carrier protein for developing glycotope-based vaccines.

Authors:  Hsiao-Ling Chiang; Chi-Yu Lin; Fan-Dan Jan; Yaoh-Shiang Lin; Chia-Tse Hsu; Jacqueline Whang-Peng; Leroy F Liu; Shin Nieh; Chun-Cheng Lin; Jaulang Hwang
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

Review 4.  Vaccine design: emerging concepts and renewed optimism.

Authors:  Sebastian K Grimm; Margaret E Ackerman
Journal:  Curr Opin Biotechnol       Date:  2013-03-07       Impact factor: 9.740

5.  Chicken IgY Fc Linked to Bordetella avium ompA and Taishan Pinus massoniana Pollen Polysaccharide Adjuvant Enhances Macrophage Function and Specific Immune Responses.

Authors:  Wenwen Dong; Hao Zhang; He Huang; Jianbo Zhou; Liping Hu; Ailing Lian; Lijun Zhu; Ningning Ma; Pingping Yang; Kai Wei; Ruiliang Zhu
Journal:  Front Microbiol       Date:  2016-11-01       Impact factor: 5.640

6.  Anti-Tumor Activity and Pharmacokinetics of AP25-Fc Fusion Protein.

Authors:  Dening Pei; Jialiang Hu; Chunming Rao; Pengcheng Yu; Hanmei Xu; Junzhi Wang
Journal:  Int J Med Sci       Date:  2019-06-10       Impact factor: 3.738

7.  A vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types.

Authors:  Xue Chen; Hongyang Liu; Ting Zhang; Yanchun Liu; Xixiu Xie; Zhirong Wang; Xuemei Xu
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.